FDA Clears AI-Powered Software for Lung Nodule Detection on Chest CT
The F.A.S.T. aiCockpit CT Lung Nodule reportedly facilitates enhanced CT workflow and automated reporting for evaluation of lung nodules
The Food and Drug Administration (FDA) has granted 510(k) clearance for the F.A.S.T. aiCockpit CT Lung Nodule, which may bolster workflow efficiencies with interpretation of chest computed tomography (CT) scans.
Available for two-dimensional (2D) and three-dimensional (3D) CT exams, the F.A.S.T. aiCockpit CT Lung Nodule facilitates efficient descriptions and measurements of lung nodules, and rejection of false positives, according to Fovia Ai, the developer of the software.
The newly FDA-cleared F.A.S.T. aiCockpit CT Lung Nodule reportedly facilitates enhanced workflows and reporting with assessment of lung nodules on chest CT scans. (Image courtesy of Fovia.Ai. (Image courtesy of Fovia.Ai.)
Once radiologists have completed their assessment and review of the findings, Fovia Ai said the F.A.S.T. aiCockpit CT Lung Nodule automatically forwards the final results for inclusion in the radiology report.
The company noted that the F.A.S.T. aiCockpit CT Lung Nodule allows for easy integration into existing PACS systems, universal viewers, and other AI platforms.
Emphasizing that the F.A.S.T. aiCockpit CT Lung Nodule is the initial component of the F.A.S.T. aiCockpit Universal AI Viewer, which will reportedly offer a variety of AI algorithms for radiology, according to Fovia.Ai.
Newsletter
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Twenty Years of CT Colonography for Colorectal Cancer Screening: What the Research Reveals
August 1st 2025Computed tomography colonography (CTC) demonstrated a 91.6 percent positive predictive value (PPV) for polyps > 6 mm, according to new research involving over 9,000 patients who underwent CTC for primary asymptomatic colorectal cancer screening.
Chest CT for Post-COVID-19 Abnormalities: Nine Takeaways from a Multi-Society Consensus Statement
August 1st 2025Developed by 21 thoracic radiologists, the new international consensus statement addresses appropriate indications, scan acquisition and keys to reporting for the use of chest CT imaging in evaluating for residual lung abnormalities from COVID-19.
Study Reveals Significant Prevalence of Abnormal PET/MRI and Dual-Energy CT Findings with Long Covid
August 1st 2025In a prospective study involving nearly 100 patients with Long Covid, 57 percent of patients had PET/MRI abnormalities and 90 percent of the cohort had abnormalities on dual-energy CT scans.
